Antibodies under a microscope

DHA29103

Research Grade Conatumumab

Description

AMG 655, TRAIL-R2mAb, XG1-048 v w, CAS: 896731-82-1

Targets

TRAILR2, TRAIL-R2, Death receptor 5, CD262, DR5, Tumor necrosis factor receptor superfamily member 10B, ZTNFR9, TRAIL receptor 2, TRICK2, TNFRSF10B, KILLER, TNF-related apoptosis-inducing ligand receptor 2

Isotype/Mimetic

IgG1-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Naive display libraries derived from human B cells

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Animal-free discovery, In vitro recombinant expression